AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
Thalidomide for previously untreated indolent or smoldering multiple myeloma
Authors: Rajkumar, SV Dispenzieri, A Fonseca, R Lacy, MQ Geyer, S Lust, JA Kyle, RA Greipp, PR Gertz, MA Witzig, TE
Citation: Sv. Rajkumar et al., Thalidomide for previously untreated indolent or smoldering multiple myeloma, LEUKEMIA, 15(8), 2001, pp. 1274-1276
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy
Authors: Fonseca, R Oken, MM Harrington, D Bailey, RJ Van Wier, SA Henderson, KJ Kay, NE Van Ness, B Greipp, PR Dewald, GW
Citation: R. Fonseca et al., Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy, LEUKEMIA, 15(6), 2001, pp. 981-986
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival
Authors: Dispenzieri, A Lacy, MQ Kyle, RA Therneau, TM Larson, DR Rajkumar, SV Fonseca, R Greipp, PR Witzig, TE Lust, JA Gertz, MA
Citation: A. Dispenzieri et al., Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival, J CL ONCOL, 19(14), 2001, pp. 3350-3356
Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Therneau, TM Kyle, RA Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Methods for estimation of bone marrow plasma cell involvement in myeloma: Predictive value for response and survival in patients undergoing autologous stem cell transplantation, AM J HEMAT, 68(4), 2001, pp. 269-275
Laboratory correlates in multiple myeloma: how useful for prognosis?
Authors: Fonseca, R Conte, G Greipp, PR
Citation: R. Fonseca et al., Laboratory correlates in multiple myeloma: how useful for prognosis?, BLOOD REV, 15(2), 2001, pp. 97-102
Angiogenesis in multiple myeloma
Authors: Rajkumar, SV Greipp, PR
Citation: Sv. Rajkumar et Pr. Greipp, Angiogenesis in multiple myeloma, BR J HAEM, 113(3), 2001, pp. 565-565
Systemic therapy of myeloma xenografts by an attenuated measles virus
Authors: Peng, KW Ahmann, GJ Pham, L Greipp, PR Cattaneo, R Russell, SJ
Citation: Kw. Peng et al., Systemic therapy of myeloma xenografts by an attenuated measles virus, BLOOD, 98(7), 2001, pp. 2002-2007
Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis
Authors: Hayman, SR Bailey, RJ Jalal, SM Ahmann, GJ Dispenzieri, A Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Rajkumar, SV Witzig, TE Lust, JA Fonseca, R
Citation: Sr. Hayman et al., Translocations involving the immunoglobulin heavy-chain locus are possibleearly genetic events in patients with primary systemic amyloidosis, BLOOD, 98(7), 2001, pp. 2266-2268
The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance
Authors: Fonseca, R Oken, MM Greipp, PR
Citation: R. Fonseca et al., The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance, BLOOD, 98(4), 2001, pp. 1271-1272
Blood levels of immune cells predict survival in myeloma patients: resultsof an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosedmultiple myeloma patients
Authors: Kay, NE Leong, TL Bone, N Vesole, DH Greipp, PR Van Ness, B Oken, MM Kyle, RA
Citation: Ne. Kay et al., Blood levels of immune cells predict survival in myeloma patients: resultsof an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosedmultiple myeloma patients, BLOOD, 98(1), 2001, pp. 23-28
A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death
Authors: Steensma, DP Gertz, MA Greipp, PR Kyle, RA Lacy, MQ Lust, JA Offord, JR Plevak, MF Therneau, TM Witzig, TE
Citation: Dp. Steensma et al., A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death, BLOOD, 97(8), 2001, pp. 2522-2523
The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic andimmunohistochemical study
Authors: Hoyer, JD Hanson, CA Fonseca, R Greipp, PR Dewald, GW Kurtin, PJ
Citation: Jd. Hoyer et al., The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic andimmunohistochemical study, AM J CLIN P, 113(6), 2000, pp. 831-837
Prognostic value of bone marrow angiogenesis in multiple myeloma
Authors: Rajkumar, SV Leong, T Roche, PC Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Kyle, RA Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Prognostic value of bone marrow angiogenesis in multiple myeloma, CLIN CANC R, 6(8), 2000, pp. 3111-3116
FISH demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis
Authors: Fonseca, R Rajkumar, SV Ahmann, GJ Jalal, SM Hoyer, JD Gertz, MA Kyle, RA Greipp, PR Dewald, GW
Citation: R. Fonseca et al., FISH demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis, LEUK LYMPH, 39(3-4), 2000, pp. 391
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders
Authors: Witzig, TE Meyers, C Therneau, T Greipp, PR
Citation: Te. Witzig et al., A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders, LEUK LYMPH, 38(3-4), 2000, pp. 345
Effect of complete response on outcome following autologous stem cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Witzig, TE Lust, JA Larson, D Therneau, TM Kyle, RA Litzow, MR Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Effect of complete response on outcome following autologous stem cell transplantation for myeloma, BONE MAR TR, 26(9), 2000, pp. 979-983
Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
Authors: Gertz, MA Lacy, MQ Inwards, DJ Gastineau, DA Tefferi, A Chen, MG Witzig, TE Greipp, PR Litzow, MR
Citation: Ma. Gertz et al., Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma, BONE MAR TR, 26(1), 2000, pp. 45-50
Thalidomide in the treatment of relapsed multiple myeloma
Authors: Rajkumar, SV Fonseca, R Dispenzieri, A Lacy, MQ Lust, JA Witzig, TE Kyle, RA Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Thalidomide in the treatment of relapsed multiple myeloma, MAYO CLIN P, 75(9), 2000, pp. 897-901
Prognostic value of serum markers of bone metabolism in untreated multiplemyeloma patients
Authors: Fonseca, R Trendle, MC Leong, T Kyle, RA Oken, MM Kay, NE Van Ness, B Greipp, PR
Citation: R. Fonseca et al., Prognostic value of serum markers of bone metabolism in untreated multiplemyeloma patients, BR J HAEM, 109(1), 2000, pp. 24-29
Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil
Authors: Kyle, RA Greipp, PR Gertz, MA Witzig, TE Lust, JA Lacy, MQ Therneau, TM
Citation: Ra. Kyle et al., Waldenstrom's macroglobulinaemia: a prospective study comparing daily withintermittent oral chlorambucil, BR J HAEM, 108(4), 2000, pp. 737-742
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis
Authors: Gertz, MA Lacy, MQ Lust, JA Greipp, PR Witzig, TE Kyle, RA
Citation: Ma. Gertz et al., Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis, MED ONCOL, 16(2), 1999, pp. 104-109
Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma
Authors: Fonseca, R Hoyer, JD Aguayo, P Jalal, SM Ahmann, GJ Rajkumar, SV Witzig, TE Lacy, MQ Dispenzieri, A Gertz, MA Kyle, RA Greipp, PR
Citation: R. Fonseca et al., Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma, LEUK LYMPH, 35(5-6), 1999, pp. 599-605
Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
Authors: Greipp, PR Trendle, MC Leong, T Oken, MM Kay, NE Van Ness, B Kyle, RA
Citation: Pr. Greipp et al., Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?, LEUK LYMPH, 35(1-2), 1999, pp. 83-89
Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: Correlation with the International Index
Authors: Ansell, SM Kurtin, PJ Stenson, M Habermann, TM Greipp, PR Therneau, TM Witzig, TE
Citation: Sm. Ansell et al., Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: Correlation with the International Index, LEUK LYMPH, 34(5-6), 1999, pp. 529-537
Prognostic factors in multiple myeloma
Authors: Rajkumar, SV Greipp, PR
Citation: Sv. Rajkumar et Pr. Greipp, Prognostic factors in multiple myeloma, HEMAT ONCOL, 13(6), 1999, pp. 1295
Risultati: 1-25 | 26-43